Telomere Dynamics and Homeostasis in a Transmissible Cancer
暂无分享,去创建一个
A. Papenfuss | K. Belov | S. Pyecroft | T. Madsen | B. Ujvari | A. Pearse | Sara Gombert | Robyn L. Taylor | Cassandra Flanagan
[1] K. Belov,et al. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population. , 2012, Cancer genetics.
[2] Carolyn Tregidgo,et al. Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer , 2012, Cell.
[3] C. Amemiya,et al. Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour , 2012, PLoS genetics.
[4] Menna E. Jones,et al. Reduced Effect of Tasmanian Devil Facial Tumor Disease at the Disease Front , 2012, Conservation biology : the journal of the Society for Conservation Biology.
[5] M. Pagel,et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination , 2011, Aging cell.
[6] K. Belov. The role of the Major Histocompatibility Complex in the spread of contagious cancers , 2011, Mammalian Genome.
[7] L. E. Donate,et al. Telomeres in cancer and ageing , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.
[8] M. Blasco,et al. Role of shelterin in cancer and aging , 2010, Aging cell.
[9] Menna E. Jones,et al. MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer , 2010, Proceedings of the Royal Society B: Biological Sciences.
[10] R. Reddel,et al. Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.
[11] Manolis Kellis,et al. The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer , 2009, Science.
[12] E. Murchison. Clonally transmissible cancers in dogs and Tasmanian devils , 2008, Oncogene.
[13] Wilhelm Palm,et al. How shelterin protects mammalian telomeres. , 2008, Annual review of genetics.
[14] H. McCallum,et al. Tasmanian devil facial tumour disease: lessons for conservation biology. , 2008, Trends in ecology & evolution.
[15] Menna E. Jones,et al. Life-history change in disease-ravaged Tasmanian devil populations , 2008, Proceedings of the National Academy of Sciences.
[16] Clare E. Hawkins,et al. Distribution and Impacts of Tasmanian Devil Facial Tumor Disease , 2007, EcoHealth.
[17] Nick J. Mooney,et al. Conservation Management of Tasmanian Devils in the Context of an Emerging, Extinction-threatening Disease: Devil Facial Tumor Disease , 2007, EcoHealth.
[18] R. Sharpe,et al. The Pathology of Devil Facial Tumor Disease (DFTD) in Tasmanian Devils (Sarcophilus harrisii) , 2006, Veterinary pathology.
[19] A. O'hara,et al. The Immunohistochemical Characterization of Devil Facial Tumor Disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii) , 2006, Veterinary pathology.
[20] P. Couppié,et al. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T‐cell leukemia , 2006, International journal of cancer.
[21] Clare E. Hawkins,et al. Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii , 2006 .
[22] A. Pearse,et al. Allograft theory: Transmission of devil facial-tumour disease , 2006, Nature.
[23] M. Blasco. Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.
[24] B. Chait,et al. TIN2 Binds TRF1 and TRF2 Simultaneously and Stabilizes the TRF2 Complex on Telomeres* , 2004, Journal of Biological Chemistry.
[25] J. Campisi,et al. TIN2 Mediates Functions of TRF2 at Human Telomeres* , 2004, Journal of Biological Chemistry.
[26] M. Pfaffl,et al. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.
[27] M. Blasco. Telomerase beyond telomeres , 2002, Nature Reviews Cancer.
[28] R. DePinho,et al. Connecting chromosomes, crisis, and cancer. , 2002, Science.
[29] R. Cawthon. Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.
[30] G. Horgan,et al. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .
[31] J. Hackett,et al. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis , 2002, Oncogene.
[32] L. Gollahon,et al. Clonal Heterogeneity in Telomerase Activity and Telomere Length in Tumor-Derived Cell Lines (44505) , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[33] L. Chin,et al. Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse , 1999, Cell.
[34] M. Hande,et al. Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice , 1999, The Journal of cell biology.
[35] R. Reddel. Telomerase and cancer. , 1997, Japanese journal of cancer research : Gann.
[36] C. Harley,et al. The telomere hypothesis of cellular aging , 1992, Experimental Gerontology.
[37] R. Moyzis,et al. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[38] Carol W. Greider,et al. Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.
[39] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[40] E. Blackburn,et al. Telomerase Targeted Therapy in Cancer and Cancer Stem Cells , 2013 .
[41] R. DePinho,et al. Telomeres and telomerase in cancer. , 2010, Carcinogenesis.
[42] T. de Lange. Telomere-related genome instability in cancer. , 2005, Cold Spring Harbor symposia on quantitative biology.